Expression of genes encoding kinin receptors in peripheral blood mononuclear cells from patients with acute coronary

J Dabek1, A Kulach, G Smolka

  • 1Department of Cardiology, Medical University of Silesia, Katowice, Poland.

Insights

Patients with acute coronary syndrome (ACS) exhibit an altered B1 receptor/B2 receptor ratio, suggesting a role for kinin signaling in the disease process. This imbalance may indicate increased activation of immune cells involved in atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Immunology

Background:

  • Inflammation is central to atherosclerosis, from plaque development to rupture causing acute coronary syndromes (ACS) like unstable angina (UA) and myocardial infarction (MI).
  • Kinins, peptides mediating inflammation and vasodilation, act via B1 and B2 receptors, but their specific role in ACS remains unclear.

Purpose of the Study:

  • To investigate the gene expression of B1 and B2 kinin receptors in patients diagnosed with ACS.
  • To determine if kinin receptor expression patterns differ between ACS patients and healthy individuals.

Main Methods:

  • Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was used to measure mRNA levels.
  • Total mRNA was extracted from peripheral blood mononuclear cells of 40 ACS patients and 10 healthy controls.
  • The ratio of B1 receptor (B1R) to B2 receptor (B2R) mRNA was calculated and compared between groups.

Main Results:

  • ACS patients displayed an inverted B1R/B2R ratio compared to healthy controls (P < 0.01 for MI vs C; P < 0.05 for UA vs C).
  • A significant decrease in B2R mRNA levels was observed in the MI group compared to controls (P < 0.05).
  • No significant differences in B1R expression were found between MI and control groups, nor were differences observed in B1R or B2R expression between UA and control groups.

Conclusions:

  • Patients with ACS present with an altered B1R/B2R ratio, indicating a potential disruption in kinin signaling pathways.
  • This disturbed kinin signaling may be linked to heightened activation of circulating mononuclear cells, which are key players in atherosclerotic plaque progression and rupture.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...